Kinetics and Fidelity of the Repair of Cas9-Induced Double-Strand DNA Breaks
- PMID: 29804829
- PMCID: PMC5993873
- DOI: 10.1016/j.molcel.2018.04.016
Kinetics and Fidelity of the Repair of Cas9-Induced Double-Strand DNA Breaks
Abstract
The RNA-guided DNA endonuclease Cas9 is a powerful tool for genome editing. Little is known about the kinetics and fidelity of the double-strand break (DSB) repair process that follows a Cas9 cutting event in living cells. Here, we developed a strategy to measure the kinetics of DSB repair for single loci in human cells. Quantitative modeling of repaired DNA in time series after Cas9 activation reveals variable and often slow repair rates, with half-life times up to ∼10 hr. Furthermore, repair of the DSBs tends to be error prone. Both classical and microhomology-mediated end joining pathways contribute to the erroneous repair. Estimation of their individual rate constants indicates that the balance between these two pathways changes over time and can be altered by additional ionizing radiation. Our approach provides quantitative insights into DSB repair kinetics and fidelity in single loci and indicates that Cas9-induced DSBs are repaired in an unusual manner.
Keywords: CRISPR-Cas; DNA double-strand break; genome editing; microhomology-mediated end-joining; non-homologous end-joining; repair kinetics.
Copyright © 2018 The Author(s). Published by Elsevier Inc. All rights reserved.
Figures








Similar articles
-
Single-Strand Annealing Plays a Major Role in Double-Strand DNA Break Repair following CRISPR-Cas9 Cleavage in Leishmania.mSphere. 2019 Aug 21;4(4):e00408-19. doi: 10.1128/mSphere.00408-19. mSphere. 2019. PMID: 31434745 Free PMC article.
-
The democratization of gene editing: Insights from site-specific cleavage and double-strand break repair.DNA Repair (Amst). 2016 Aug;44:6-16. doi: 10.1016/j.dnarep.2016.05.001. Epub 2016 May 12. DNA Repair (Amst). 2016. PMID: 27261202 Free PMC article. Review.
-
[Small Molecular Inhibitors of DNA Double Strand Break Repair Pathways Increase the ANTI-HBV Activity of CRISPR/Cas9].Mol Biol (Mosk). 2019 Mar-Apr;53(2):311-323. doi: 10.1134/S0026898419010075. Mol Biol (Mosk). 2019. PMID: 31099781 Russian.
-
CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites.Nat Commun. 2019 Jun 28;10(1):2866. doi: 10.1038/s41467-019-10735-7. Nat Commun. 2019. PMID: 31253785 Free PMC article.
-
Precision genome editing in the CRISPR era.Biochem Cell Biol. 2017 Apr;95(2):187-201. doi: 10.1139/bcb-2016-0137. Epub 2016 Sep 29. Biochem Cell Biol. 2017. PMID: 28177771 Review.
Cited by
-
Making gene editing accessible in resource limited environments: recommendations to guide a first-time user.Front Genome Ed. 2024 Sep 25;6:1464531. doi: 10.3389/fgeed.2024.1464531. eCollection 2024. Front Genome Ed. 2024. PMID: 39386178 Free PMC article. Review.
-
TREX2 enables efficient genome disruption mediated by paired CRISPR-Cas9 nickases that generate 3'-overhanging ends.Mol Ther Nucleic Acids. 2023 Nov 2;34:102072. doi: 10.1016/j.omtn.2023.102072. eCollection 2023 Dec 12. Mol Ther Nucleic Acids. 2023. PMID: 38028195 Free PMC article.
-
A cohesin/HUSH- and LINC-dependent pathway controls ribosomal DNA double-strand break repair.Genes Dev. 2019 Sep 1;33(17-18):1175-1190. doi: 10.1101/gad.324012.119. Epub 2019 Aug 8. Genes Dev. 2019. PMID: 31395742 Free PMC article.
-
The origin of unwanted editing byproducts in gene editing.Acta Biochim Biophys Sin (Shanghai). 2022 May 25;54(6):767-781. doi: 10.3724/abbs.2022056. Acta Biochim Biophys Sin (Shanghai). 2022. PMID: 35643959 Free PMC article.
-
A Novel Anti-Cancer Therapy: CRISPR/Cas9 Gene Editing.Front Pharmacol. 2022 Jul 22;13:939090. doi: 10.3389/fphar.2022.939090. eCollection 2022. Front Pharmacol. 2022. PMID: 35935840 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials